the Food and Drug Administration now lists the status of Eli Lilly’s Zepbound and Mounjaro as “available,” after nearly two years of shortages. The increased supply has renewed the focus on ...

affordability, and ease to evidence-based medications for qualified members,” said Scott Honken, PharmD, Chief Commercial Officer, WeightWatchers. “Zepbound vials offer an affordable treatment ...

affordability, and ease to evidence-based medications for qualified members,” said Scott Honken, PharmD, Chief Commercial Officer, WeightWatchers. “Zepbound vials offer an affordable treatment ...

affordability, access and effectiveness of these offerings. Some know these drugs through brand names such as Ozempic, Wegovy, Mounjaro or Zepbound. Others know it as semaglutide. They all belong ...

Amir Daftari is a Newsweek reporter based in London, specializing in global affairs with a focus on the Middle ... costs reaching $1,000 to $1,300, affordability remains a significant barrier.